Psoriasis is a common skin condition caused by an over active immune system. The result is rapid buildup of skin cells on the skin’s surface resulting in inflammation, flaking, and itching of the skin. It most commonly affects the elbows, knees and scalp but can occur anywhere.

About 7 millions Americans, both males and females and the young and the old, are affected by this condition. It is not contagious but lack of public knowledge about the disease can lead to social stigma and discrimination of the affected individuals.

Recently, researchers have discovered that people with severe psoriasis can also have inflammation in other parts of the body resulting in psoriatic arthritis, heart disease, diabetes, hypertension and depression.

Treatments for psoriasis have evolved over time and our specialists at Central Connecticut Dermatology are proud to have been a part of the effort to bring new treatments to people with this disease.

If you are suffering from psoriasis, and traditional therapy has been ineffective, you may be eligible for a clinical trial of a potential novel treatment option. Please contact our office for more information.

Current Studies:

FDA approved Skyrizi for individuals with moderate to severe plaque psoriasis that have failed Taltz or Cosentyx